Eli Lilly and Company - Change Receivables

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Change-Receivables" stands at -2.45 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2024, the lowest value since 09/30/2022.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -2.15 Billion United States Dollars compared to the value the year prior.
The 1 year change is -2.15 Billion United States Dollars.
The 3 year change is 2.73 Billion United States Dollars.
The 5 year change is -1.07 Billion United States Dollars.
The 10 year change is -2.30 Billion United States Dollars.

The Serie's long term average value is -1.59 Billion United States Dollars. It's latest available value, on 09/30/2024, is -0.859 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2020, to it's latest available value, on 09/30/2024, is +2.95 Billion.
The Serie's change in United States Dollars from it's maximum value, on 12/31/2012, to it's latest available value, on 09/30/2024, is -2.81 Billion.